MyFinsight
Home
Blog
About
Proceeds from sales and
maturities of short-term...
-$8,098,254
Net proceeds from
sales of common stock...
$138,365
Net cash provided by
(used in) investing...
$1,460,326
(159.70%↑ Y/Y)
Net cash provided by
financing activities
$138,365
(-97.02%↓ Y/Y)
Canceled cashflow
$6,637,928
Net increase
(decrease) in cash and cash...
-$202,937
(-41.75%↓ Y/Y)
Canceled cashflow
$1,598,691
Stock compensation
$408,387
(-66.22%↓ Y/Y)
Accrued expenses
$218,239
(1264.50%↑ Y/Y)
Accounts payable
$71,349
(-7.17%↓ Y/Y)
Accounts receivable
-$27,886
(-155.99%↓ Y/Y)
Amortization
$20,325
(105.05%↑ Y/Y)
Depreciation
$2,737
something is missing
-$5,589,606
Purchase of short-term
investments
$1,000,536
(-95.02%↓ Y/Y)
Purchase of patents
$28,411
(-19.32%↓ Y/Y)
Purchase of trademarks
$19,375
(119.15%↑ Y/Y)
Net cash used in
operating activities
-$1,801,628
(23.12%↑ Y/Y)
Canceled cashflow
$748,923
Net loss
-$2,239,170
(37.27%↑ Y/Y)
Prepaid expenses and
other current assets
$211,580
(522.43%↑ Y/Y)
Inventory
$53,973
(3464.90%↑ Y/Y)
Gain on sale of
short-term investments
$8,016
(-84.75%↓ Y/Y)
Back
Back
Cash Flow
Nexalin Technology, Inc. (NXL)
Nexalin Technology, Inc. (NXL)
source: myfinsight.com